Debra Swoverland
Physician Assistant · Traverse City, MINPI 1730500562
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 838 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 47 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 838 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- GSK$1K
- AstraZeneca$1K
- Novo Nordisk$928
- Lilly USA, LLC$875
- Amgen$718
- plus $7K from 41 others
What the payments were for
- Food & beverage$13,776100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$250
- Repatha$110
- Auvelity$101
How this compares
$13,783 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 142 | $106,025 |
| MounjaroTirzepatide | 75 | $78,077 |
| RexultiBrexpiprazole | 19 | $61,167 |
| FarxigaDapagliflozin Propanediol | 68 | $54,677 |
| OzempicSemaglutide | 38 | $43,191 |
| TrulicityDulaglutide | 23 | $36,779 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 44 | $35,246 |
| EliquisApixaban | 30 | $28,162 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 52 | $23,507 |
| JardianceEmpagliflozin | 15 | $22,806 |
| VraylarCariprazine Hcl | 13 | $18,909 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $14,022 |
| MyrbetriqMirabegron | 16 | $13,440 |
| QuliptaAtogepant | 12 | $12,608 |
| KerendiaFinerenone | 13 | $11,678 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $1,376 | $129,532194 claims |
| Lilly USA, LLCMounjaro, Trulicity | $875 | $114,85698 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,157 | $68,70087 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $337 | $61,16719 claims |
| Novo NordiskOzempic | $928 | $43,19138 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $79 | $35,24644 claims |
| AbbVieVraylar, Qulipta | $1,727 | $31,51725 claims |
| PfizerEliquis | $503 | $28,16230 claims |
| Boehringer IngelheimJardiance | $386 | $22,80615 claims |
| Astellas Pharma US IncMyrbetriq | $518 | $13,44016 claims |
| BayerKerendia | $345 | $11,67813 claims |
| MerckBelsomra | $184 | $7,03416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Traverse City
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
- Gabrielle DamoreRoyal Oak$200K
- Melissa MickelsonKalamazoo$168K
- Patrick CooneyNew Baltimore$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.